FDA
- Application: ANDA211812
- Marketing authorisation holder: TEVA PHARMS USA INC
- Local brand name: OXYMETAZOLINE
- Indication: CREAM — TOPICAL
- Status: approved
Oxymetazoline hydrochloride Cream, 1% (Oxymetazoline hydrochloride Cream, 1%) regulatory status in United States.
Yes. FDA has authorised it.
TEVA PHARMS USA INC holds the US marketing authorisation.